miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer.
about
Roles for miRNAs in endocrine resistance in breast cancerDecoding the usefulness of non-coding RNAs as breast cancer markersApoptomiRs of Breast Cancer: Basics to ClinicsEmerging therapies for breast cancerEvaluation of circulating miRNAs in wet age-related macular degeneration.Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management.Critical analysis of the potential for microRNA biomarkers in breast cancer management.Expression of microRNA-10a, microRNA-342-3p and their predicted target gene TIAM1 in extranodal NK/T-cell lymphoma, nasal type.miR-342 overexpression results in a synthetic lethal phenotype in BRCA1-mutant HCC1937 breast cancer cellsmiR-342 regulates BRCA1 expression through modulation of ID4 in breast cancer.Oestrogen receptor negativity in breast cancer: a cause or consequence?miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.Functional proteomics outlines the complexity of breast cancer molecular subtypes.Tamoxifen sensitivity-related microRNA-342 is a useful biomarker for breast cancer survival.A Potential Prognostic Long Noncoding RNA Signature to Predict Recurrence among ER-positive Breast Cancer Patients Treated with Tamoxifen.Estradiol and the Development of the Cerebral Cortex: An Unexpected Role?Cancer epigenetics: Moving forward.microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine TherapyLoss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic metabolic reprogramming in triple negative breast cancer
P2860
Q26783076-ED0C45B1-D616-42C7-993B-51DD891004A3Q28069370-5C0C7B5B-DE51-44CF-B36C-EB45DAD8E0E9Q28072414-E8CFE074-3A13-4F6B-A630-6F765D634AA3Q33617949-247A50B6-8F1C-455B-8DC0-5C86A96B320EQ33964372-A536E914-0B68-4284-9673-417D2B35B350Q35094742-2305A02D-F691-4B45-8482-A1B57E3FAFF7Q35137273-581C1E37-8E31-4CD5-8947-A205C30B59E5Q36502791-E66CDD3B-CA8F-4875-A400-4FF1D4DADDE4Q37109827-7D1E8146-04CB-4678-8524-80C3A06187BEQ37521015-BE16FCC3-698D-4137-9B77-84332DCFD6D2Q37529397-9AD41CCC-9CD9-4C7E-9913-A74BD47994A8Q38442897-193ADDCE-6C48-4074-A48A-5CB43358D8ACQ41564586-D33DC5DA-A6A0-4972-95A7-048D540511BFQ47153443-84FB18C0-5294-4E45-A6EB-8D52D9C4D8D3Q49912442-D8F92173-483C-4EAD-9BF1-1AB99AE24D5CQ54974230-78E26C62-8E7D-4449-AC0C-230D5AB2E362Q55177661-B3256D09-9E70-430C-963B-BB3BBB4C1432Q57106025-08BDD382-5CAC-49AE-843F-E5B75D403809Q58774468-3734C63C-B458-4996-8E3F-564B2A1087E2
P2860
miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@ast
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@en
type
label
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@ast
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@en
prefLabel
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@ast
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@en
P2093
P2860
P356
P1476
miR-342 is associated with est ...... to tamoxifen in breast cancer.
@en
P2093
En-Qi Qiao
Jian-Zhong Wu
Jin-Hai Tang
Ming-Hua Ji
Yue-Jun He
P2860
P304
P356
10.3892/ETM.2013.915
P577
2013-01-22T00:00:00Z